Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Masimo ( (MASI) ) just unveiled an announcement.
On January 12, 2026, Masimo announced select preliminary financial results for the fourth quarter and full year 2025, ahead of its full earnings release scheduled for February 26, 2026. For the fourth quarter of 2025, the company expects revenue of about $411 million, up roughly 12% on a reported basis and 11% in constant currency, non-GAAP earnings per diluted share above $1.54 despite the impact of new tariffs, and shipments of approximately 69,000 noninvasive technology boards and instruments. For full-year 2025, Masimo projects revenue of about $1.523 billion, representing around 9% growth on both a reported and constant currency basis, non-GAAP earnings per diluted share above $5.55 at the high end of its guidance range, and shipments of about 270,000 noninvasive technology boards and instruments. Management highlighted that record incremental contract value from new customers and expanded hospital agreements underpinned the year’s performance, suggesting strengthened competitive positioning and a foundation for sustained operational momentum, though the figures remain subject to adjustment upon completion of the annual audit.
The most recent analyst rating on (MASI) stock is a Hold with a $135.00 price target. To see the full list of analyst forecasts on Masimo stock, see the MASI Stock Forecast page.
Spark’s Take on MASI Stock
According to Spark, TipRanks’ AI Analyst, MASI is a Neutral.
Masimo’s overall stock score reflects significant financial challenges, with declining revenues and profitability being the most impactful factors. Despite this, strategic corporate events and positive earnings call highlights provide some optimism for future growth and operational improvements.
To see Spark’s full report on MASI stock, click here.
More about Masimo
Masimo Corporation (Nasdaq: MASI), based in Irvine, California, operates in the healthcare technology and medical devices industry, focusing on noninvasive monitoring solutions such as technology boards and instruments used in hospitals and other clinical settings. The company’s growth is closely tied to hospital contracts and expanded agreements with existing healthcare customers, reflecting its emphasis on enterprise-scale monitoring deployments and recurring value from long-term customer relationships.
Average Trading Volume: 742,350
Technical Sentiment Signal: Sell
Current Market Cap: $7.41B
For an in-depth examination of MASI stock, go to TipRanks’ Overview page.